CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge.

Cancers (Basel) · 2020 · PMC7563142 · PMID 32882980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

A recent report demonstrated that there was a numerical trend favoring ribociclib versus placebo for time to deterioration in global health-related quality of life (HRQoL).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.